Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional ...
WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- More than 350 biotech investors, executives, and economists today called on the Congressional Budget Office (CBO) to update how it assesses the impact of federal drug pricing legislation to ensure that policies …